McLaren Macomb
Mount Clemens, Michigan, United States
General hospital in Mount Clemens, Michigan
1000 Harrington St, Mt Clemens, MI 48043
About McLaren Macomb
"McLaren Macomb is a 288-bed tertiary teaching facility located in Mount Clemens, Michigan. McLaren Macomb provides a full range of services, including cardiovascular care at the Mat Gaberty Heart Center, award winning cancer services at the Ted B. Wahby Cancer Center, comprehensive orthopedic services and a state-of-the-art elective Surgery Center. The hospital is verified as a Level II Trauma Center and operates one of the busiest Emergency Centers in the area."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
13
NSABP Foundation Inc
4
Alliance for Clinical Trials in Oncology
2
Michigan State University
2
Yale University
2
A.T. Still University of Health Sciences
1
Abbott Medical Devices
1
American Heart Association
1
Angel Medical Systems
1
Boehringer Ingelheim
1
Duke University
1
Clinical Trials at McLaren Macomb
During the past decade, McLaren Macomb conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 19 clinical trials were completed, i.e. on
average, 380% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
2004-07-01
2011-07-01
Completed
242
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Is Osteopathic Manipulative Treatment (OMT) Beneficial for Elderly Patients Hospitalized With Pneumonia?
2004-03-01
2007-04-01
Completed
406
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo
2006-10-01
2017-07-11
Completed
624
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
2006-08-01
2023-12-01
Active, not recruiting
3,966
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
2005-10-01
2012-07-01
Completed
981
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "McLaren Macomb" #1 sponsor was "SWOG Cancer Research Network" with 13 trials, followed by "NSABP Foundation Inc" with 4 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Michigan State University" with 2 trials sponsored and "Yale University"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Macomb"
#1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Novartis" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were
collaborators in the rest 28 trials.
Clinical Trials Conditions at McLaren Macomb
According to Clinical.Site data, the most researched conditions in "McLaren Macomb" are
"Breast Cancer" (11 trials), "Prostate Cancer" (5 trials), "Lung Cancer" (4 trials), "Atrial Fibrillation" (3 trials) and "Coronary Artery Disease" (3 trials). Many other conditions were trialed in "McLaren Macomb" in a lesser frequency.
Clinical Trials Intervention Types at McLaren Macomb
Most popular intervention types in "McLaren Macomb" are "Drug" (21 trials), "Other" (12 trials), "Biological" (4 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials), "bevacizumab" (3 trials) and "biologic sample preservation procedure" (3 trials). Other intervention names were less common.
Clinical Trials Genders at McLaren Macomb
The vast majority of trials in "McLaren Macomb" are
24 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at McLaren Macomb
Currently, there are NaN active trials in "McLaren Macomb".
undefined are not yet recruiting,
2 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 27 completed trials in McLaren Macomb,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in McLaren Macomb, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of McLaren Macomb
McLaren Macomb has several departments that took part in Clinical trials: "Michigan Vascular Center/McLaren- Flint" - 2 trials, "McLaren Bay Heart and Vascular" - 2 trials
Departments List
Name
City
Trials